114 related articles for article (PubMed ID: 16512978)
1. Interactions between hypoxia and epidermal growth factor receptor in non-small-cell lung cancer.
Swinson DE; O'Byrne KJ
Clin Lung Cancer; 2006 Jan; 7(4):250-6. PubMed ID: 16512978
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia-inducible factor-1 alpha in non small cell lung cancer: relation to growth factor, protease and apoptosis pathways.
Swinson DE; Jones JL; Cox G; Richardson D; Harris AL; O'Byrne KJ
Int J Cancer; 2004 Aug; 111(1):43-50. PubMed ID: 15185341
[TBL] [Abstract][Full Text] [Related]
3. Prognostic implications of hypoxia-inducible factor-1α in epidermal growth factor receptor-negative non-small cell lung cancer.
Park S; Ha SY; Cho HY; Chung DH; Kim NR; Hong J; Cho EK
Lung Cancer; 2011 Apr; 72(1):100-7. PubMed ID: 20822827
[TBL] [Abstract][Full Text] [Related]
4. Activated epidermal growth factor receptor-Stat-3 signaling promotes tumor survival in vivo in non-small cell lung cancer.
Haura EB; Zheng Z; Song L; Cantor A; Bepler G
Clin Cancer Res; 2005 Dec; 11(23):8288-94. PubMed ID: 16322287
[TBL] [Abstract][Full Text] [Related]
5. Combined effects of EGFR tyrosine kinase inhibitors and vATPase inhibitors in NSCLC cells.
Jin HO; Hong SE; Kim CS; Park JA; Kim JH; Kim JY; Kim B; Chang YH; Hong SI; Hong YJ; Park IC; Lee JK
Toxicol Appl Pharmacol; 2015 Aug; 287(1):17-25. PubMed ID: 25981168
[TBL] [Abstract][Full Text] [Related]
6. Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer.
Giatromanolaki A; Koukourakis MI; Sivridis E; Pastorek J; Wykoff CC; Gatter KC; Harris AL
Cancer Res; 2001 Nov; 61(21):7992-8. PubMed ID: 11691824
[TBL] [Abstract][Full Text] [Related]
7. Erlotinib-cisplatin combination inhibits growth and angiogenesis through c-MYC and HIF-1α in EGFR-mutated lung cancer in vitro and in vivo.
Lee JG; Wu R
Neoplasia; 2015 Feb; 17(2):190-200. PubMed ID: 25748238
[TBL] [Abstract][Full Text] [Related]
8. α5 Nicotinic acetylcholine receptor mediates nicotine-induced HIF-1α and VEGF expression in non-small cell lung cancer.
Ma X; Jia Y; Zu S; Li R; Jia Y; Zhao Y; Xiao D; Dang N; Wang Y
Toxicol Appl Pharmacol; 2014 Jul; 278(2):172-9. PubMed ID: 24793809
[TBL] [Abstract][Full Text] [Related]
9. KLF5 promotes hypoxia-induced survival and inhibits apoptosis in non-small cell lung cancer cells via HIF-1α.
Li X; Liu X; Xu Y; Liu J; Xie M; Ni W; Chen S
Int J Oncol; 2014 Oct; 45(4):1507-14. PubMed ID: 25051115
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of hypoxia-inducible factor-1alpha mRNA and its clinical significance in non-small cell lung cancer.
Yohena T; Yoshino I; Takenaka T; Kameyama T; Ohba T; Kuniyoshi Y; Maehara Y
J Thorac Oncol; 2009 Mar; 4(3):284-90. PubMed ID: 19190516
[TBL] [Abstract][Full Text] [Related]
11. In vitro study of normoxic epidermal growth factor receptor-induced hypoxia-inducible factor-1-alpha, vascular endothelial growth factor, and BNIP3 expression in head and neck squamous cell carcinoma cell lines: Implications for anti-epidermal growth factor receptor therapy.
Secades P; de Santa-María IS; Merlo A; Suarez C; Chiara MD
Head Neck; 2015 Aug; 37(8):1150-62. PubMed ID: 24798801
[TBL] [Abstract][Full Text] [Related]
12. DEC1 (STRA13) protein expression relates to hypoxia- inducible factor 1-alpha and carbonic anhydrase-9 overexpression in non-small cell lung cancer.
Giatromanolaki A; Koukourakis MI; Sivridis E; Turley H; Wykoff CC; Gatter KC; Harris AL
J Pathol; 2003 Jun; 200(2):222-8. PubMed ID: 12754744
[TBL] [Abstract][Full Text] [Related]
13. [Prognostic value of the expression of vascular endothelial growth factor A and hypoxia-inducible factor 1alpha in patients undergoing surgery for non-small cell lung cancer].
Honguero Martínez AF; Arnau Obrer A; Figueroa Almazán S; Martínez Hernández N; Guijarro Jorge R
Med Clin (Barc); 2014 May; 142(10):432-7. PubMed ID: 23948151
[TBL] [Abstract][Full Text] [Related]
14. Thioredoxin-1 modulates transcription of cyclooxygenase-2 via hypoxia-inducible factor-1alpha in non-small cell lung cancer.
Csiki I; Yanagisawa K; Haruki N; Nadaf S; Morrow JD; Johnson DH; Carbone DP
Cancer Res; 2006 Jan; 66(1):143-50. PubMed ID: 16397226
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression.
Rusch V; Klimstra D; Venkatraman E; Pisters PW; Langenfeld J; Dmitrovsky E
Clin Cancer Res; 1997 Apr; 3(4):515-22. PubMed ID: 9815714
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene.
Song X; Liu X; Chi W; Liu Y; Wei L; Wang X; Yu J
Cancer Chemother Pharmacol; 2006 Dec; 58(6):776-84. PubMed ID: 16532342
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-inducible factor (HIF-1) and its relationship to apoptosis and proliferation in lung cancer.
Volm M; Koomägi R
Anticancer Res; 2000; 20(3A):1527-33. PubMed ID: 10928066
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of HIF-2α induced by sorafenib contributes to the resistance by activating the TGF-α/EGFR pathway in hepatocellular carcinoma cells.
Zhao D; Zhai B; He C; Tan G; Jiang X; Pan S; Dong X; Wei Z; Ma L; Qiao H; Jiang H; Sun X
Cell Signal; 2014 May; 26(5):1030-9. PubMed ID: 24486412
[TBL] [Abstract][Full Text] [Related]
19. Apigenin inhibits expression of vascular endothelial growth factor and angiogenesis in human lung cancer cells: implication of chemoprevention of lung cancer.
Liu LZ; Fang J; Zhou Q; Hu X; Shi X; Jiang BH
Mol Pharmacol; 2005 Sep; 68(3):635-43. PubMed ID: 15947208
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-8 stimulates cell proliferation in non-small cell lung cancer through epidermal growth factor receptor transactivation.
Luppi F; Longo AM; de Boer WI; Rabe KF; Hiemstra PS
Lung Cancer; 2007 Apr; 56(1):25-33. PubMed ID: 17175059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]